Letter to the Editor: Impact of non-alcoholic steatohepatitis on liver-related outcomes in chronic hepatitis B.
We read with great interest the article by Choi et al.(1) reporting the impacts of concomitant non-alcoholic steatohepatitis (NASH) on the clinical outcomes and all-cause mortality in chronic hepatitis B (CHB) patients. Although the number of patients and follow-up duration are quite impressive, several points require further clarification.